To our knowledge, evidence exists on a few genetic variants in relation to long-term survival from coronary heart disease and cardiovascular disease among patients with these diseases, such as variants in the gene coding for adenosine monophosphate (AMP) deaminase 1 (AMPD1) [28] and paraoxonase 1 [29]. This evidence concerns the gene AMPD1 and coronary artery disorder.